Source-Omega LLC was cited for marketing three omega-3 algae oil products (Source Oil Rosemary Algae Omega-3, Source Oil Organic Lemon Algae Omega-3, and Source Oil Organic Orange Algae Omega-3) as drugs without FDA approval by making disease claims on their website. The company violated the Federal Food, Drug, and Cosmetic Act by claiming the products could prevent or treat conditions including Alzheimer's disease, high triglycerides, cognitive deficiencies, and cancer—claims that established the products as intended for use in the cure, mitigation, treatment, or prevention of disease. The violations were identified during an FDA review of the company's website in May 2023, which documented specific claims such as stating that DHA could prevent up to 70% of Alzheimer's cases and was more effective than many drugs for certain conditions.